Management of Primary Plasma Cell Leukemia Remains Challenging Even in the Era of Novel Agents

por Chaulagain, Chakra P, Diacovo, Maria-Julia, Van, Amy, Martinez, Felipe, Fu, Chieh-Lin, Jimenez Jimenez, Antonio Martin, Ahmed, Wesam, Anwer, Faiz
Publicado 2021

Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplant

por Jimenez Jimenez, Antonio, Komanduri, Krishna, Brown, Samantha, Wang, Trent, Pereira, Denise, Goodman, Mark, Beitinjaneh, Amer, Lekakis, Lazaros, Chinapen, Stephanie, Devlin, Sean, Ponce, Doris, Sauter, Craig, Perales, Miguel-Angel, Shaffer, Brian C.
Publicado 2022

Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia

por Gui, Gege, Dillon, Laura W., Ravindra, Niveditha, Hegde, Pranay S., Andrew, Georgia, Mukherjee, Devdeep, Wong, Zoë, Auletta, Jeffery, El Chaer, Firas, Chen, Evan, Chen, Yi-Bin, Corner, Adam, Devine, Steven M., Iyer, Sunil, Jimenez Jimenez, Antonio Martin, De Lima, Marcos J.G., Litzow, Mark R., Kebriaei, Partow, Spellman, Stephen R, Zeger, Scott L., Page, Kristin M., Hourigan, Christopher S.
Publicado 2023